Search for: "Doe v. Mylan Pharmaceuticals, Inc."
Results 1 - 20
of 163
Sort by Relevance
|
Sort by Date
9 Apr 2024, 2:56 pm
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
13 Mar 2024, 7:24 pm
” (see also Hoechst-Roussel Pharms., Inc. v. [read post]
9 Feb 2024, 11:08 am
” Similarly, as show in the Mylan Laby’s, Inc. v. [read post]
5 Apr 2023, 5:18 am
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
1 Oct 2022, 2:31 pm
The outcome: Mylan Pharmaceuticals Inc. [read post]
26 Sep 2022, 4:49 am
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
17 Mar 2022, 2:32 pm
Mylan Pharmaceuticals Inc. [read post]
1 Feb 2022, 1:22 pm
Mylan Pharmaceuticals Inc., Docket No. 21-01729 (Fed. [read post]
5 Nov 2021, 8:29 am
Similarly, MPI and Mylan Inc. [read post]
10 Nov 2020, 8:53 pm
Mylan... [read post]
6 Nov 2020, 7:16 am
” On the facts here: Mylan Pharmaceuticals Inc. [read post]
31 Jul 2020, 9:40 am
U.S.A., Inc. v. [read post]
21 Apr 2020, 6:30 am
In Valeant Pharmaceuticals International, Inc. v. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 May 2019, 11:24 am
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
8 May 2019, 7:14 am
Genus Lifesciences Inc. v. [read post]
11 Mar 2019, 7:08 pm
In the 2017 Phigenix v. [read post]